GPC-100 Is a Novel CXCR4 Inhibitor That Leads to Improved in Vitro Potency and In Vivo Efficacy in Stem Cell Mobilization When Combined with a Beta-Blocker

Authors :: Juan Jose Fung
Valerie Chiou
Jaemin Lee
Yongdae Jang
Junhee Choi
Piotr Zalicki
Thomas Cayton
Ashley Chin
Niña Caculitan
SoHui Kim
Jiyeong Lee
Devki Sukhtankar
Eunhee Kim
Josephine Cardarelli
Source :: Blood. 140:4489-4490
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools